Rigel Pharmaceuticals (RIGL) Stock Forecast, Price & News

Rigel Pharmaceuticals (NASDAQ:RIGL) Frequently Asked Questions

Is Rigel Pharmaceuticals a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Rigel Pharmaceuticals in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Rigel Pharmaceuticals stock.
View analyst ratings for Rigel Pharmaceuticals or view top-rated stocks.

When is Rigel Pharmaceuticals' next earnings date?

Rigel Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Tuesday, August 2nd 2022.
View our earnings forecast for Rigel Pharmaceuticals.

How were Rigel Pharmaceuticals' earnings last quarter?

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) posted its quarterly earnings data on Tuesday, May, 3rd. The biotechnology company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.12) by $0.04. The biotechnology company earned $16.74 million during the quarter, compared to analyst estimates of $18.49 million. Rigel Pharmaceuticals had a negative trailing twelve-month return on equity of 219.06% and a negative net margin of 99.89%. During the same quarter in the previous year, the company posted $0.22 earnings per share.
View Rigel Pharmaceuticals' earnings history.

What price target have analysts set for RIGL?

3 brokerages have issued 1-year price targets for Rigel Pharmaceuticals' shares. Their forecasts range from $4.00 to $11.00. On average, they anticipate Rigel Pharmaceuticals' stock price to reach $7.67 in the next year. This suggests a possible upside of 325.9% from the stock's current price.
View analysts' price targets for Rigel Pharmaceuticals or view top-rated stocks among Wall Street analysts.

Who are Rigel Pharmaceuticals' key executives?

Rigel Pharmaceuticals' management team includes the following people:

• Mr. Raul R. Rodriguez, Pres, CEO & Director (Age 61, Pay $979.34k)
• Mr. Dean L. Schorno CPA, Exec. VP & CFO (Age 59, Pay $623.46k)
• Ms. Dolly A. Vance, Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec. (Age 57, Pay $810.06k)
• Dr. Wolfgang Dummer M.D., Ph.D., Exec. VP & Chief Medical Officer (Age 56, Pay $644.05k)
• Mr. David A. Santos, Exec. VP & Chief Commercial Officer (Age 59, Pay $600.64k)
• Mr. Joseph Lasaga, Exec. VP of Corp. Devel. (Age 47)
• Dr. Esteban S. Masuda, Exec. VP of Research (Age 60)
• Mr. Tarek Sallam, VP of Marketing

What is Raul Rodriguez's approval rating as Rigel Pharmaceuticals' CEO?

6 employees have rated Rigel Pharmaceuticals CEO Raul Rodriguez on Glassdoor.com. Raul Rodriguez has an approval rating of 84% among Rigel Pharmaceuticals' employees.

Who are some of Rigel Pharmaceuticals' key competitors?

Some companies that are related to Rigel Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seagen (SGEN), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), United Therapeutics (UTHR), Exact Sciences (EXAS), Repligen (RGEN), Neurocrine Biosciences (NBIX), Halozyme Therapeutics (HALO) and Exelixis (EXEL).
View all of RIGL's competitors.

What other stocks do shareholders of Rigel Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rigel Pharmaceuticals investors own include ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Zosano Pharma (ZSAN), Sorrento Therapeutics (SRNE), Aeterna Zentaris (AEZS), KushCo (KSHB), Novan (NOVN), Bionano Genomics (BNGO), OrganiGram (OGI) and Pennsylvania Real Estate Investment Trust (PEI).

What is Rigel Pharmaceuticals' stock symbol?

Rigel Pharmaceuticals trades on the NASDAQ under the ticker symbol "RIGL."

Who are Rigel Pharmaceuticals' major shareholders?

Rigel Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (9.63%), Vanguard Group Inc. (5.31%), State Street Corp (4.37%), Rock Springs Capital Management LP (2.86%), Lord Abbett & CO. LLC (2.56%) and Great Point Partners LLC (2.32%).
View institutional ownership trends for Rigel Pharmaceuticals.

Which major investors are selling Rigel Pharmaceuticals stock?

RIGL stock was sold by a variety of institutional investors in the last quarter, including Tamarack Advisers LP, Goldman Sachs Group Inc., State Street Corp, Great Point Partners LLC, Candriam Luxembourg S.C.A., Dimensional Fund Advisors LP, Rhenman & Partners Asset Management AB, and UBS Group AG.
View insider buying and selling activity for Rigel Pharmaceuticals or view top insider-selling stocks.

Which major investors are buying Rigel Pharmaceuticals stock?

RIGL stock was acquired by a variety of institutional investors in the last quarter, including Woodline Partners LP, Assenagon Asset Management S.A., J. Goldman & Co LP, Walleye Capital LLC, Acadian Asset Management LLC, Graham Capital Management L.P., Renaissance Technologies LLC, and Vanguard Group Inc..
View insider buying and selling activity for Rigel Pharmaceuticals or or view top insider-buying stocks.

How do I buy shares of Rigel Pharmaceuticals?

Shares of RIGL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Rigel Pharmaceuticals' stock price today?

One share of RIGL stock can currently be purchased for approximately $1.80.

How much money does Rigel Pharmaceuticals make?

Rigel Pharmaceuticals has a market capitalization of $309.69 million and generates $149.24 million in revenue each year. The biotechnology company earns $-17.91 million in net income (profit) each year or ($0.490010) on an earnings per share basis.

How many employees does Rigel Pharmaceuticals have?

Rigel Pharmaceuticals employs 165 workers across the globe.

When was Rigel Pharmaceuticals founded?

Rigel Pharmaceuticals was founded in 1996.

What is Rigel Pharmaceuticals' official website?

The official website for Rigel Pharmaceuticals is www.rigel.com.

How can I contact Rigel Pharmaceuticals?

Rigel Pharmaceuticals' mailing address is 1180 VETERANS BOULEVARD, SOUTH SAN FRANCISCO CA, 94080. The biotechnology company can be reached via phone at (650) 624-1100, via email at [email protected], or via fax at 650-624-1101.